Abstract 4586: Balancing Mortality Benefit vs. Bleeding Risk for Intensive Antiplatelet Therapy among Acute Coronary Syndrome Patients: Insights from the CRUSADE Registry
Tracy Y Wang(Duke Medical Center), Eric D. Peterson(The University of Texas Southwestern Medical Center), E. Magnus Ohman(Tarzana Treatment Centers), Matthew T. Roe(Clinical Research Institute), Anita Y. Chen(University of Rochester Medicine), W. Brian Gibler(University of Cincinnati)
Circulation
October 28, 2008
Cited by 1
Related Papers
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
|Circulation|2011|1.8k
Bivalirudin for Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2006|1.5k